Skip to main content
. 2014 Apr 7;20(13):3516–3524. doi: 10.3748/wjg.v20.i13.3516

Table 2.

Reactivation in patients with inflammatory bowel disease undergoing immunosuppressive therapy

Ref. HBsAg+ HBcAb+ HCV+
Loras et al[60] 9/25 0/65 8/51
Morisco et al[65] 1/6 1/4 1/10
Papa et al[54] 0/1 0/22 0/4

HBsAg: Hepatitis B surface antigen; HBcAb: Hepatitis B core antibody; HCV: Hepatitis C virus.